Pfizer Inc. (PFE)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Pfizer Inc. (PFE)
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Key Insights
Critical company metrics and information
Share Price
$25.73Market Cap
$145.81 BillionTotal Outstanding Shares
5.67 Billion SharesTotal Employees
88,000Dividend
$0.42 Per Share QuarterlyIPO Date
June 22, 1951SIC Description
Pharmaceutical PreparationsHomepage
https://www.pfizer.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Exchange Gains/Losses | $-38.00 Million |
Net Cash Flow From Operating Activities, Continuing | $11.26 Billion |
Net Cash Flow From Investing Activities | $-6.72 Billion |
Net Cash Flow, Continuing | $-2.04 Billion |
Net Cash Flow | $-2.08 Billion |
Net Cash Flow From Financing Activities | $-6.58 Billion |
Net Cash Flow From Investing Activities, Continuing | $-6.72 Billion |
Net Cash Flow From Financing Activities, Continuing | $-6.58 Billion |
Net Cash Flow From Operating Activities | $11.26 Billion |
Income Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Preferred Stock Dividends And Other Adjustments | $0.00 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Selling, General, and Administrative Expenses | $15.03 Billion |
Costs And Expenses | $55.47 Billion |
Gross Profit | $39.87 Billion |
Benefits Costs and Expenses | $55.47 Billion |
Diluted Earnings Per Share | $0.74 |
Diluted Average Shares | $11.40 Billion |
Interest Expense, Operating | $3.04 Billion |
Income/Loss From Continuing Operations Before Tax | $3.90 Billion |
Operating Income/Loss | $3.90 Billion |
Basic Earnings Per Share | $0.76 |
Revenues | $59.38 Billion |
Other Operating Expenses | $20.94 Billion |
Net Income/Loss Attributable To Parent | $4.25 Billion |
Basic Average Shares | $11.33 Billion |
Income/Loss From Discontinued Operations Net Of Tax | $-22.00 Million |
Net Income/Loss Available To Common Stockholders, Basic | $4.25 Billion |
Income Tax Expense/Benefit | $-402.00 Million |
Net Income/Loss | $4.28 Billion |
Income Tax Expense/Benefit, Deferred | $-3.56 Billion |
Cost Of Revenue | $19.50 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $32.00 Million |
Income/Loss From Continuing Operations After Tax | $4.30 Billion |
Operating Expenses | $35.97 Billion |
Balance Sheet
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Other Current Assets | $31.50 Billion |
Current Assets | $43.22 Billion |
Wages | $3.38 Billion |
Noncurrent Assets | $176.25 Billion |
Liabilities And Equity | $219.48 Billion |
Fixed Assets | $18.54 Billion |
Current Liabilities | $43.21 Billion |
Liabilities | $126.92 Billion |
Equity Attributable To Noncontrolling Interest | $272.00 Million |
Inventory | $11.72 Billion |
Other Current Liabilities | $34.51 Billion |
Intangible Assets | $59.99 Billion |
Noncurrent Liabilities | $83.71 Billion |
Equity | $92.56 Billion |
Accounts Payable | $5.31 Billion |
Assets | $219.48 Billion |
Other Non-current Assets | $97.73 Billion |
Equity Attributable To Parent | $92.29 Billion |
Historical Dividends
Current dividend: $0.42 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 9, 2024 | Dec 2, 2024 | Nov 8, 2024 | $0.42 | Quarterly |
Jun 26, 2024 | Sep 3, 2024 | Jul 26, 2024 | $0.42 | Quarterly |
Apr 24, 2024 | Jun 14, 2024 | May 10, 2024 | $0.42 | Quarterly |
Dec 14, 2023 | Mar 1, 2024 | Jan 26, 2024 | $0.42 | Quarterly |
Oct 4, 2023 | Dec 4, 2023 | Nov 10, 2023 | $0.41 | Quarterly |
Jun 22, 2023 | Sep 5, 2023 | Jul 28, 2023 | $0.41 | Quarterly |
Apr 26, 2023 | Jun 9, 2023 | May 12, 2023 | $0.41 | Quarterly |
Dec 9, 2022 | Mar 3, 2023 | Jan 27, 2023 | $0.41 | Quarterly |
Sep 22, 2022 | Dec 5, 2022 | Nov 4, 2022 | $0.4 | Quarterly |
Jun 23, 2022 | Sep 6, 2022 | Jul 29, 2022 | $0.4 | Quarterly |
Apr 28, 2022 | Jun 10, 2022 | May 13, 2022 | $0.4 | Quarterly |
Dec 10, 2021 | Mar 4, 2022 | Jan 28, 2022 | $0.4 | Quarterly |
Sep 23, 2021 | Dec 6, 2021 | Nov 5, 2021 | $0.39 | Quarterly |
Jun 24, 2021 | Sep 7, 2021 | Jul 30, 2021 | $0.39 | Quarterly |
Apr 22, 2021 | Jun 4, 2021 | May 7, 2021 | $0.39 | Quarterly |
Dec 11, 2020 | Mar 5, 2021 | Jan 29, 2021 | $0.39 | Quarterly |
Sep 24, 2020 | Dec 1, 2020 | Nov 6, 2020 | $0.38 | Quarterly |
Jun 25, 2020 | Sep 1, 2020 | Jul 31, 2020 | $0.38 | Quarterly |
Apr 23, 2020 | Jun 5, 2020 | May 8, 2020 | $0.38 | Quarterly |
Dec 16, 2019 | Mar 6, 2020 | Jan 31, 2020 | $0.38 | Quarterly |
Sep 24, 2019 | Dec 2, 2019 | Nov 8, 2019 | $0.36 | Quarterly |
Jun 27, 2019 | Sep 3, 2019 | Aug 2, 2019 | $0.36 | Quarterly |
Apr 25, 2019 | Jun 7, 2019 | May 10, 2019 | $0.36 | Quarterly |
Dec 14, 2018 | Mar 1, 2019 | Feb 1, 2019 | $0.36 | Quarterly |
Sep 27, 2018 | Dec 3, 2018 | Nov 9, 2018 | $0.34 | Quarterly |
Jun 28, 2018 | Sep 4, 2018 | Aug 3, 2018 | $0.34 | Quarterly |
Apr 26, 2018 | Jun 1, 2018 | May 11, 2018 | $0.34 | Quarterly |
Dec 18, 2017 | Mar 1, 2018 | Feb 2, 2018 | $0.34 | Quarterly |
Sep 27, 2017 | Dec 1, 2017 | Nov 10, 2017 | $0.32 | Quarterly |
Jun 22, 2017 | Sep 1, 2017 | Aug 4, 2017 | $0.32 | Quarterly |
Apr 27, 2017 | Jun 1, 2017 | May 12, 2017 | $0.32 | Quarterly |
Dec 12, 2016 | Mar 1, 2017 | Feb 3, 2017 | $0.32 | Quarterly |
Sep 22, 2016 | Dec 1, 2016 | Nov 11, 2016 | $0.3 | Quarterly |
Jun 23, 2016 | Sep 1, 2016 | Aug 5, 2016 | $0.3 | Quarterly |
Apr 28, 2016 | Jun 1, 2016 | May 13, 2016 | $0.3 | Quarterly |
Dec 14, 2015 | Mar 2, 2016 | Feb 5, 2016 | $0.3 | Quarterly |
Sep 25, 2015 | Dec 1, 2015 | Nov 6, 2015 | $0.28 | Quarterly |
Jun 25, 2015 | Sep 2, 2015 | Aug 7, 2015 | $0.28 | Quarterly |
Apr 23, 2015 | Jun 2, 2015 | May 8, 2015 | $0.28 | Quarterly |
Dec 15, 2014 | Mar 3, 2015 | Feb 6, 2015 | $0.28 | Quarterly |
Oct 23, 2014 | Dec 2, 2014 | Nov 7, 2014 | $0.26 | Quarterly |
Jun 26, 2014 | Sep 3, 2014 | Aug 1, 2014 | $0.26 | Quarterly |
Apr 24, 2014 | Jun 3, 2014 | May 9, 2014 | $0.26 | Quarterly |
Dec 16, 2013 | Mar 4, 2014 | Feb 7, 2014 | $0.26 | Quarterly |
Oct 24, 2013 | Dec 3, 2013 | Nov 8, 2013 | $0.24 | Quarterly |
Jun 27, 2013 | Sep 4, 2013 | Aug 2, 2013 | $0.24 | Quarterly |
Apr 25, 2013 | Jun 4, 2013 | May 10, 2013 | $0.24 | Quarterly |
Dec 17, 2012 | Mar 5, 2013 | Feb 1, 2013 | $0.24 | Quarterly |
Oct 25, 2012 | Dec 4, 2012 | Nov 9, 2012 | $0.22 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Pfizer Inc. (PFE)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.